Loading company…
Riskpilot
← Back to search
Sign in
Get full access
EXCELLENT TECH. PRODUCTS ApS
APS
Dissolved
CVR 30530543
Rygårds Allé 104
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2008
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2014
DKK 1,4M
-346% vs 2013
EBITDA margin
100.0%
+346% vs 2013
Equity ratio
-1909.5%
Financial strength
Net profit 2014
DKK -1,8M
-199% vs 2013
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2012
-1M
-200%
2013
1M
+200%
2014
Key figures
Annual report 2014
Revenue
DKK 1,4M
-346%
EBITDA
DKK 1,4M
+346%
Net profit
DKK -1,8M
-199%
Total assets
DKK 126K
-91%
Equity
DKK -2,4M
-303%
Employees
—
—
Company information
Legal name
EXCELLENT TECH. PRODUCTS ApS
CVR number
30530543
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
3. oktober 2008
Share capital
DKK 126.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2014-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør.
Contact
Address
Rygårds Allé 104
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2012
-1M
2013
1M
2014
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2012
-1M
2013
1M
2014
Income statement
DKK thousands
Item
2012
2013
2014
Revenue
786
-582
1.435
Staff expenses
-0
-0
-0
EBITDA
786
-582
1.435
Depreciation & amort.
-0
-0
-0
EBIT
786
-582
1.435
Net financials
-178
-24
100
Profit before tax
608
-606
1.535
Tax
743
-0
3.346
Net profit
-135
-606
-1.811
Balance sheet
DKK thousands
Item
2012
2013
2014
Total assets
1.675
1.413
126
Equity
9
-597
-2.408
Long-term debt
0
0
0
Short-term debt
1.666
2.010
2.535
Total debt
1.666
2.010
2.535
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2012
2014
Equity ratio
-1909.5%
This company
38.2%
Market median
-5099% vs market
2012
2014
Return on equity
-181148700.0%
This company
18.4%
Market median
-984503904% vs market
2012
2014
Net profit margin
-126.2%
This company
8.1%
Market median
-1658% vs market
2012
2014
Asset turnover
11.38×
This company
1.12×
Market median
+916% vs market
2012
2014
Debt / equity
1.05×
This company
0.62×
Market median
-69% vs market
2012
2014
Annual reports & filings
Annual report 2014
Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
View
PDF
Annual report 2013
Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
View
PDF
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
LI
Lars Inge Wallentin Björkholm
Management
Management
2008
—
—
FC
Frederik Claes Hübinette
Management
Management
2008
—
—
NA
Nils Are Ljung
Chief Executive Officer
Chief Executive Officer
2015
—
—
JT
Jan Thomas Alban Kull
Founder
Founder
2008
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
FC
Frederik Claes Hübinette
Chairman
2010
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Uppsalagruppen Medical AB
Individual
100.0%
100.0%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of EXCELLENT TECH. PRODUCTS ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Lars Inge Wallentin Björkholm
Management
0 companies
Frederik Claes Hübinette
Management
0 companies
Nils Are Ljung
Chief Executive Officer
0 companies
Jan Thomas Alban Kull
Founder
0 companies
Frederik Claes Hübinette
Chairman
0 companies